Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,710
+$4,360 QoQ
Shares Held
139
+1290.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#185
of 197 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $237,724,862 across 405 Biotechnology names. NAMS ranks #248 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
90,236 | $28,522,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,586 | $24,630,851 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
372,588 | $20,469,983 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
217,577 | $16,205,134 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
176,973 | $13,851,674 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
45,298 | $13,636,055 | |
| 7 | VCEL |
Vericel Corp
|
182,038 | $8,098,869 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,423 | $7,746,234 |
All Filings in NAMS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,710 | 139 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $350 | 10 | Shares | Defined | 2026-02-17 | |
| 2024-12-31 | $3,649 | 142 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $3,103 | 187 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $864 | 45 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||